Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L GELLER

Showing results (181-190 of 489) with videos related to

Pageof 49
Sort By:
Biometrics|April 21, 2001
Closed testing procedures for group sequential clinical trials with multiple endpointsD I Tang, N L Geller
Biometrics|April 5, 2019
Discussion of "A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III" by Andrew G. Chapple and Peter F. ThallEric S Leifer, Nancy L Geller
The Journal of Biological Chemistry|August 10, 1982
Rat liver Cu,Zn-superoxide dismutase. Subcellular location in lysosomesB L Geller, D R Winge
Psychiatric Services (Washington, D.C.)|July 4, 2006
The recovery model and seclusion and restraintKris A McLoughlin, Jeffrey L Geller
Hospital & Community Psychiatry|January 1, 1985
Competency to stand trial: neuroleptic medication and demeanor in courtJ L Geller, P S Appelbaum
Biometrics|June 1, 1991
On the choice of times for data analysis in group sequential clinical trialsZ H Li, N L Geller
Psychiatric Services (Washington, D.C.)|August 2, 2014
Personal accounts: recovery is resilience in the face of symptomsRichard J Stewart, Jeffrey L Geller
Sovetskaia Meditsina|January 1, 1987
[Extraintestinal complications of nonspecific ulcerative colitis and Crohn's disease]L I Geller, A L Geller
Sovetskaia Meditsina|January 1, 1987
[Effect of pentagastrin on gastric secretion and blood flow in the gastric mucosa in chronic gastritis]L I Geller, A L Geller
Antimicrobial Agents and Chemotherapy|December 24, 2004
Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coliJesse Deere, Pat Iversen, Bruce L Geller
Pageof 49

Showing results (181-190 of 489) with videos related to

Sort By:
Pageof 49
Biometrics|April 21, 2001
Closed testing procedures for group sequential clinical trials with multiple endpointsD I Tang, N L Geller
Biometrics|April 5, 2019
Discussion of "A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III" by Andrew G. Chapple and Peter F. ThallEric S Leifer, Nancy L Geller
The Journal of Biological Chemistry|August 10, 1982
Rat liver Cu,Zn-superoxide dismutase. Subcellular location in lysosomesB L Geller, D R Winge
Psychiatric Services (Washington, D.C.)|July 4, 2006
The recovery model and seclusion and restraintKris A McLoughlin, Jeffrey L Geller
Hospital & Community Psychiatry|January 1, 1985
Competency to stand trial: neuroleptic medication and demeanor in courtJ L Geller, P S Appelbaum
Biometrics|June 1, 1991
On the choice of times for data analysis in group sequential clinical trialsZ H Li, N L Geller
Psychiatric Services (Washington, D.C.)|August 2, 2014
Personal accounts: recovery is resilience in the face of symptomsRichard J Stewart, Jeffrey L Geller
Sovetskaia Meditsina|January 1, 1987
[Extraintestinal complications of nonspecific ulcerative colitis and Crohn's disease]L I Geller, A L Geller
Sovetskaia Meditsina|January 1, 1987
[Effect of pentagastrin on gastric secretion and blood flow in the gastric mucosa in chronic gastritis]L I Geller, A L Geller
Antimicrobial Agents and Chemotherapy|December 24, 2004
Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coliJesse Deere, Pat Iversen, Bruce L Geller
Pageof 49